Skip to main content
. Author manuscript; available in PMC: 2010 Feb 17.
Published in final edited form as: J Biomed Opt. 2008 Mar–Apr;13(2):021108. doi: 10.1117/1.2892687

Fig. 5.

Fig. 5

(a) Typical mean transcutaneous spectrum (gray) and typical mean exposed bone spectrum (black) (b) Recovered bone factor without an optical clearing agent (gray), recovered bone factor after glycerol application (black), and exposed bone measurement (dotted)